Earnings Feed
Start Free
SEATTLE GENETICS INC /WA·4/A

Jul 12, 7:53 PM ET

JP MORGAN PARTNERS GLOBAL INVESTORS SELLDOWN LLP 4/A

4/A · SEATTLE GENETICS INC /WA · Filed Jul 12, 2007

Insider Transaction Report

Form 4/AAmended
Period: 2007-07-09
SEATTLE GENETICS INC /WASGEN
JP MORGAN PARTNERS BHCA LP
10% Owner
Transactions
  • Conversion

    Class A Common Stock

    [F7]
    2007-07-09+2,263,980→ 2,263,980 total
  • Conversion

    Class A Common Stock

    [F7][F1]
    2007-07-09+559,850→ 559,850 total(indirect: See Footnote)
  • Conversion

    Class A Common Stock

    [F7][F2]
    2007-07-09+284,160→ 284,160 total(indirect: See Footnote)
  • Conversion

    Class A Common Stock

    [F7][F11][F3]
    2007-07-09+76,320→ 76,320 total(indirect: See Footnote)
  • Conversion

    Class A Common Stock

    [F7][F4]
    2007-07-09+31,660→ 31,660 total(indirect: See Footnote)
  • Conversion

    Class A Common Stock

    [F7][F5]
    2007-07-09+210,390→ 210,390 total(indirect: See Footnote)
  • Conversion

    Class A Common Stock

    [F7][F6]
    2007-07-09+1,058,640→ 1,058,640 total(indirect: See Footnote)
  • Conversion

    Series A Convertible Preferred Stock

    [F7][F12][F10][F8]
    2007-07-09−226,398→ 0 total
    Exercise: $2.50From: 2004-07-08→ Common Stock (2,263,980 underlying)
  • Conversion

    Series A Convertible Preferred Stock

    [F7][F12][F10][F8][F1]
    2007-07-09−55,985→ 0 total(indirect: See Footnote)
    Exercise: $2.50From: 2004-07-08→ Common Stock (559,850 underlying)
  • Conversion

    Series A Convertible Preferred Stock

    [F7][F12][F10][F8][F2]
    2007-07-09−28,416→ 0 total(indirect: See Footnote)
    Exercise: $2.50From: 2004-07-08→ Common Stock (284,160 underlying)
  • Conversion

    Series A Convertible Preferred Stock

    [F7][F12][F10][F8][F3]
    2007-07-09−7,632→ 0 total(indirect: See Footnote)
    Exercise: $2.50From: 2004-07-08→ Common Stock (76,320 underlying)
  • Conversion

    Series A Convertible Preferred Stock

    [F7][F12][F10][F8][F4]
    2007-07-09−3,166→ 0 total(indirect: See Footnote)
    Exercise: $2.50From: 2004-07-08→ Common Stock (31,660 underlying)
  • Conversion

    Series A Convertible Preferred Stock

    [F7][F12][F10][F8][F5]
    2007-07-09−21,039→ 0 total(indirect: See Footnote)
    Exercise: $2.50From: 2004-07-08→ Common Stock (210,390 underlying)
  • Conversion

    Series A Convertible Preferred Stock

    [F7][F12][F10][F8][F6]
    2007-07-09−105,864→ 0 total(indirect: See Footnote)
    Exercise: $2.50From: 2004-07-08→ Common Stock (1,058,640 underlying)
Holdings

  • Warrants

    Exercise: $6.25From: 2003-07-08Exp: 2011-12-31→ Common Stock (469,594 underlying)
    469,594

  • Warrants

    [F1]
    (indirect: See Footnote)
    Exercise: $6.25From: 2003-07-08Exp: 2011-12-31→ Common Stock (101,421 underlying)
    101,421

  • Warrants

    [F2]
    (indirect: See Footnote)
    Exercise: $6.25From: 2003-07-08Exp: 2011-12-31→ Common Stock (13,826 underlying)
    13,826

  • Warrants

    [F3]
    (indirect: See Footnote)
    Exercise: $6.25From: 2003-07-08Exp: 2011-12-31→ Common Stock (51,478 underlying)
    51,478

  • Warrants

    [F4]
    (indirect: See Footnote)
    Exercise: $6.25From: 2003-07-08Exp: 2011-12-31→ Common Stock (5,736 underlying)
    5,736

  • Warrants

    [F5]
    (indirect: See Footnote)
    Exercise: $6.25From: 2003-07-08Exp: 2011-12-31→ Common Stock (38,114 underlying)
    38,114

  • Warrants

    [F6]
    (indirect: See Footnote)
    Exercise: $6.25From: 2003-07-08Exp: 2011-12-31→ Common Stock (132,331 underlying)
    132,331

  • Stock Options (Right to Purchase)

    [F9]
    (indirect: See Footnote)
    Exercise: $7.26From: 2005-05-16Exp: 2014-05-16→ Common Stock (10,000 underlying)
    10,000

  • Stock Options (Right to Purchase)

    [F9]
    (indirect: See Footnote)
    Exercise: $5.11From: 2006-05-12Exp: 2015-05-12→ Common Stock (10,000 underlying)
    10,000

  • Stock Options (Right to Purchase)

    [F9]
    (indirect: See Footnote)
    Exercise: $10.20From: 2008-05-24Exp: 2017-05-25→ Common Stock (10,000 underlying)
    10,000
Footnotes (12)
  • [F1]The amount shown represents the beneficial ownership of the Issuer's equity securities by J.P. Morgan Partners Global Investors, L.P. The Reporting Person has no pecuniary interest in such securities.
  • [F10]N/A.
  • [F11]This filing is being amended to correct the amount of securities beneficially owned in Table I, Row 4, Box 5 which were previously reported as 79,320. The correct amount is 76,320.
  • [F12]This filing is being amended to correct the dates in Table II, Rows 8-14, Box 3. The dates listed on the filing previously submitted on 7/11/2007 were 2/9/2007. The correct dates are 7/9/2007.
  • [F2]The amount shown represents the beneficial ownership of the Issuer's equity securities by J.P. Morgan Partners Global Investors (Cayman), L.P. The Reporting Person has no pecuniary interest in such securities.
  • [F3]The amount shown represents the beneficial ownership of the Issuer's equity securities by J.P. Morgan Partners Global Investors A, L.P. The Reporting Person has no pecuniary interest in such securities.
  • [F4]The amount shown represents the beneficial ownership of the Issuer's equity securities by J.P. Morgan Partners Global Investors (Cayman) II, L.P. The Reporting Person has no pecuniary interest in such securities.
  • [F5]The amount shown represents the beneficial ownership of the Issuer's equity securities by J.P. Morgan Partners Global Investors (Selldown), L.P. The Reporting Person has no pecuniary interest in such securities.
  • [F6]The amount shown represents the beneficial ownership of the Issuer's equity securities by J.P. Morgan Partners Global Investors (Selldown II), L.P. The Reporting Person has no pecuniary interest in such securities.
  • [F7]The conversion price of the Series A Convertible Preferred Stock is equal to the initial purchase price divided by $2.50, as adjusted for stock splits, stock dividends, combinations and other similar capitalizations of the Issuer's Common and Preferred Stock. Initially this results in a 1 for 10 conversion ratio. Each share of Series A Convertible Preferred Stock is entitled to 0.93 votes for each share of Common Stock into which such share of Convertible Preferred Stock could then be converted.
  • [F8]All outstanding shares of the Issuer's Series A Convertible Preferred Stock are convertible at the holder's option into shares of the Issuer's Common Stock on a 10 to 1 basis any time after July 8, 2004. This right to convert does not expire.
  • [F9]These options were granted to Srinivas Akkaraju, a director of the Issuer. Mr. Akkaraju is obligated to transfer any shares issued under the Stock Option to J.P. Morgan Partners (BHCA), L.P. ("JPM BHCA") at the request of JPM BHCA.
Signature
/s/ J.P. Morgan Partners (BHCA), L.P., By: JPMP Master Fund Manager, L.P., its general partner, By: JPMP Capital Corp., its general partner, By: John C. Wilmot|2007-07-12

Documents

2 files